{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:45:36Z","timestamp":1788191136852,"version":"build-2803163510"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,10,27]],"date-time":"2018-10-27T00:00:00Z","timestamp":1540598400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,10,27]],"date-time":"2018-10-27T00:00:00Z","timestamp":1540598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA042172"],"award-info":[{"award-number":["DA042172"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00213-018-5067-5","type":"journal-article","created":{"date-parts":[[2018,10,27]],"date-time":"2018-10-27T15:27:43Z","timestamp":1540654063000},"page":"1079-1095","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Cognitive deficits and neurotoxicity induced by synthetic cathinones: is there a role for neuroinflammation?"],"prefix":"10.1007","volume":"236","author":[{"given":"Jonna M.","family":"Leyrer-Jackson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin K.","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2517-0351","authenticated-orcid":false,"given":"M. Foster","family":"Olive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,27]]},"reference":[{"key":"5067_CR1","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.neuro.2014.07.004","volume":"44C","author":"A Adam","year":"2014","unstructured":"Adam A, Gerecsei LI, Lepesi N, Csillag A (2014) Apoptotic effects of the 'designer drug' methylenedioxypyrovalerone (MDPV) on the neonatal mouse brain. Neurotoxicology 44C:231\u2013236","journal-title":"Neurotoxicology"},{"key":"5067_CR2","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/dta.224","volume":"3","author":"SL Aleryani","year":"2011","unstructured":"Aleryani SL, Aleryani RA, Al-Akwa AA (2011) Khat a drug of abuse: roles of free radicals and antioxidants. Drug Test Anal 3:548\u2013551","journal-title":"Drug Test Anal"},{"key":"5067_CR3","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1471-4159.2011.07632.x","volume":"120","author":"M Angoa-Perez","year":"2012","unstructured":"Angoa-Perez M, Kane MJ, Francescutti DM, Sykes KE, Shah MM, Mohammed AM, Thomas DM, Kuhn DM (2012) Mephedrone, an abused psychoactive component of 'bath salts' and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum. J Neurochem 120:1097\u20131107","journal-title":"J Neurochem"},{"key":"5067_CR4","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/jnc.12114","volume":"125","author":"M Angoa-Perez","year":"2013","unstructured":"Angoa-Perez M, Kane MJ, Briggs DI, Francescutti DM, Sykes CE, Shah MM, Thomas DM, Kuhn DM (2013) Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA. J Neurochem 125:102\u2013110","journal-title":"J Neurochem"},{"key":"5067_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.lfs.2013.07.015","volume":"97","author":"M Angoa-Perez","year":"2014","unstructured":"Angoa-Perez M, Kane MJ, Herrera-Mundo N, Francescutti DM, Kuhn DM (2014) Effects of combined treatment with mephedrone and methamphetamine or 3,4-methylenedioxymethamphetamine on serotonin nerve endings of the hippocampus. Life Sci 97:31\u201336","journal-title":"Life Sci"},{"key":"5067_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/7854_2016_21","volume":"32","author":"M Angoa-Perez","year":"2017","unstructured":"Angoa-Perez M, Anneken JH, Kuhn DM (2017) Neurotoxicology of synthetic cathinone analogs. Curr Top Behav Neurosci 32:209\u2013230","journal-title":"Curr Top Behav Neurosci"},{"key":"5067_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/jnc.13048","volume":"133","author":"JH Anneken","year":"2015","unstructured":"Anneken JH, Angoa-Perez M, Kuhn DM (2015) 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: beta-ketoamphetamine modulation of neurotoxicity by the dopamine transporter. J Neurochem 133:211\u2013222","journal-title":"J Neurochem"},{"key":"5067_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1124\/jpet.116.237768","volume":"360","author":"JH Anneken","year":"2017","unstructured":"Anneken JH, Angoa-Perez M, Sati GC, Crich D, Kuhn DM (2017) Dissecting the influence of two structural substituents on the differential neurotoxic effects of acute methamphetamine and mephedrone treatment on dopamine nerve endings with the use of 4-methylmethamphetamine and methcathinone. J Pharmacol Exp Ther 360:417\u2013423","journal-title":"J Pharmacol Exp Ther"},{"key":"5067_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.neuropharm.2017.08.033","volume":"134","author":"JH Anneken","year":"2018","unstructured":"Anneken JH, Angoa-Perez M, Sati GC, Crich D, Kuhn DM (2018) Assessing the role of dopamine in the differential neurotoxicity patterns of methamphetamine, mephedrone, methcathinone and 4-methylmethamphetamine. Neuropharmacology 134:46\u201356","journal-title":"Neuropharmacology"},{"key":"5067_CR10","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00204-014-1278-7","volume":"89","author":"AM Araujo","year":"2015","unstructured":"Araujo AM, Valente MJ, Carvalho M, Dias da Silva D, Gaspar H, Carvalho F, de Lourdes Bastos M, Guedes de Pinho P (2015) Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of 'legal high' packages containing synthetic cathinones. Arch Toxicol 89:757\u2013771","journal-title":"Arch Toxicol"},{"key":"5067_CR11","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jemermed.2013.11.104","volume":"46","author":"ML Banks","year":"2014","unstructured":"Banks ML, Worst TJ, Rusyniak DE, Sprague JE (2014) Synthetic cathinones (\u201cbath salts\u201d). J Emerg Med 46:632\u2013642","journal-title":"J Emerg Med"},{"key":"5067_CR12","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1111\/add.12601","volume":"109","author":"MH Baumann","year":"2014","unstructured":"Baumann MH (2014) Awash in a sea of \u2018bath salts\u2019: implications for biomedical research and public health. Addiction 109:1577\u20131579","journal-title":"Addiction"},{"key":"5067_CR13","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/npp.2011.304","volume":"37","author":"MH Baumann","year":"2012","unstructured":"Baumann MH, Ayestas MA Jr, Partilla JS, Sink JR, Shulgin AT, Daley PF, Brandt SD, Rothman RB, Ruoho AE, Cozzi NV (2012) The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology 37:1192\u20131203","journal-title":"Neuropsychopharmacology"},{"key":"5067_CR14","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/npp.2012.204","volume":"38","author":"MH Baumann","year":"2013","unstructured":"Baumann MH, Partilla JS, Lehner KR, Thorndike EB, Hoffman AF, Holy M, Rothman RB, Goldberg SR, Lupica CR, Sitte HH, Brandt SD, Tella SR, Cozzi NV, Schindler CW (2013) Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products. Neuropsychopharmacology 38:552\u2013562","journal-title":"Neuropsychopharmacology"},{"key":"5067_CR15","doi-asserted-by":"crossref","unstructured":"Baumann MH, Volkow ND (2016) Abuse of new psychoactive substances: threats and solutions. Neuropsychopharmacology 41:663\u2013665.","DOI":"10.1038\/npp.2015.260"},{"key":"5067_CR16","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/glia.22966","volume":"64","author":"K Bisht","year":"2016","unstructured":"Bisht K, Sharma KP, Lecours C, Sanchez MG, El Hajj H, Milior G, Olmos-Alonso A, Gomez-Nicola D, Luheshi G, Vallieres L, Branchi I, Maggi L, Limatola C, Butovsky O, Tremblay ME (2016) Dark microglia: a new phenotype predominantly associated with pathological states. Glia 64:826\u2013839","journal-title":"Glia"},{"key":"5067_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12906-016-1145-6","volume":"16","author":"T Bogale","year":"2016","unstructured":"Bogale T, Engidawork E, Yisma E (2016) Subchronic oral administration of crude khat extract (Catha edulis forsk) induces schizophernic-like symptoms in mice. BMC Complement Altern Med 16:153","journal-title":"BMC Complement Altern Med"},{"key":"5067_CR18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.pharep.2016.10.006","volume":"69","author":"B Budzynska","year":"2017","unstructured":"Budzynska B, Michalak A, Frankowska M, Kaszubska K, Biala G (2017) Acute behavioral effects of co-administration of mephedrone and MDMA in mice. Pharmacol Rep 69:199\u2013205","journal-title":"Pharmacol Rep"},{"key":"5067_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fneur.2013.00189","volume":"4","author":"JL Cadet","year":"2013","unstructured":"Cadet JL, Bisagno V (2013) The primacy of cognition in the manifestations of substance use disorders. Front Neurol 4:189","journal-title":"Front Neurol"},{"key":"5067_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00401-013-1221-7","volume":"127","author":"JL Cadet","year":"2014","unstructured":"Cadet JL, Bisagno V, Milroy CM (2014) Neuropathology of substance use disorders. Acta Neuropathol 127:91\u2013107","journal-title":"Acta Neuropathol"},{"key":"5067_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.taap.2015.12.019","volume":"293","author":"A Ciudad-Roberts","year":"2016","unstructured":"Ciudad-Roberts A, Duart-Castells L, Camarasa J, Pubill D, Escubedo E (2016) The combination of ethanol with mephedrone increases the signs of neurotoxicity and impairs neurogenesis and learning in adolescent CD-1 mice. Toxicol Appl Pharmacol 293:10\u201320","journal-title":"Toxicol Appl Pharmacol"},{"key":"5067_CR22","first-page":"219","volume":"1","author":"LS Colzato","year":"2010","unstructured":"Colzato LS, Ruiz MJ, van den Wildenberg WP, Bajo MT, Hommel B (2010) Long-term effects of chronic khat use: impaired inhibitory control. Front Psychol 1:219","journal-title":"Front Psychol"},{"key":"5067_CR23","first-page":"6","volume":"e20602","author":"LS Colzato","year":"2011","unstructured":"Colzato LS, Ruiz MJ, van de Wildenberg WP, Hommel B (2011) Khat use is associated with impaired working memory and cognitive flexibility. PLoS One e20602:6","journal-title":"PLoS One"},{"key":"5067_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-801284-0.00001-4","volume":"118","author":"C Cui","year":"2014","unstructured":"Cui C, Shurtleff D, Harris RA (2014) Neuroimmune mechanisms of alcohol and drug addiction. Int Rev Neurobiol 118:1\u201312","journal-title":"Int Rev Neurobiol"},{"key":"5067_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.pbb.2016.05.003","volume":"146-147","author":"JJ Daniel","year":"2016","unstructured":"Daniel JJ, Hughes RN (2016) Increased anxiety and impaired spatial memory in young adult rats following adolescent exposure to methylone. Pharmacol Biochem Behav 146-147:44\u201349","journal-title":"Pharmacol Biochem Behav"},{"key":"5067_CR26","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1177\/0269881116662635","volume":"30","author":"EB de Sousa Fernandes Perna","year":"2016","unstructured":"de Sousa Fernandes Perna EB, Papaseit E, Perez-Mana C, Mateus J, Theunissen EL, Kuypers K, de la Torre R, Farre M, Ramaekers JG (2016) Neurocognitive performance following acute mephedrone administration, with and without alcohol. J Psychopharmacol 30:1305\u20131312","journal-title":"J Psychopharmacol"},{"key":"5067_CR27","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/npp.2012.179","volume":"38","author":"AC Dean","year":"2013","unstructured":"Dean AC, Groman SM, Morales AM, London ED (2013) An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans. Neuropsychopharmacology 38:259\u2013274","journal-title":"Neuropsychopharmacology"},{"key":"5067_CR28","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.pbb.2012.10.006","volume":"103","author":"B den Hollander","year":"2013","unstructured":"den Hollander B, Rozov S, Linden AM, Uusi-Oukari M, Ojanpera I, Korpi ER (2013) Long-term cognitive and neurochemical effects of \u201cbath salt\u201d designer drugs methylone and mephedrone. Pharmacol Biochem Behav 103:501\u2013509","journal-title":"Pharmacol Biochem Behav"},{"key":"5067_CR29","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/toxsci\/kfu108","volume":"141","author":"B den Hollander","year":"2014","unstructured":"den Hollander B, Sundstrom M, Pelander A, Ojanpera I, Mervaala E, Korpi ER, Kankuri E (2014) Keto amphetamine toxicity-focus on the redox reactivity of the cathinone designer drug mephedrone. Toxicol Sci 141:120\u2013131","journal-title":"Toxicol Sci"},{"key":"5067_CR30","doi-asserted-by":"publisher","first-page":"14924","DOI":"10.1038\/srep14924","volume":"5","author":"B den Hollander","year":"2015","unstructured":"den Hollander B, Sundstrom M, Pelander A, Siltanen A, Ojanpera I, Mervaala E, Korpi ER, Kankuri E (2015) Mitochondrial respiratory dysfunction due to the conversion of substituted cathinones to methylbenzamides in SH-SY5Y cells. Sci Rep 5:14924","journal-title":"Sci Rep"},{"key":"5067_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.neuropharm.2018.01.020","volume":"133","author":"SB Dolan","year":"2018","unstructured":"Dolan SB, Chen Z, Huang R, Gatch MB (2018) \"ecstasy\" to addiction: mechanisms and reinforcing effects of three synthetic cathinone analogs of MDMA. Neuropharmacology 133:171\u2013180","journal-title":"Neuropharmacology"},{"key":"5067_CR32","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1177\/0269881106061153","volume":"20","author":"N Easton","year":"2006","unstructured":"Easton N, Marsden CA (2006) Ecstasy: are animal data consistent between species and can they translate to humans? J Psychopharmacol 20:194\u2013210","journal-title":"J Psychopharmacol"},{"key":"5067_CR33","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s11481-013-9490-4","volume":"8","author":"BJ Eggen","year":"2013","unstructured":"Eggen BJ, Raj D, Hanisch UK, Boddeke HW (2013) Microglial phenotype and adaptation. J NeuroImmune Pharmacol 8:807\u2013823","journal-title":"J NeuroImmune Pharmacol"},{"key":"5067_CR34","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1345\/aph.1Q628","volume":"46","author":"JA Fass","year":"2012","unstructured":"Fass JA, Fass AD, Garcia AS (2012) Synthetic cathinones (bath salts): legal status and patterns of abuse. Ann Pharmacother 46:436\u2013441","journal-title":"Ann Pharmacother"},{"key":"5067_CR35","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.bbr.2018.04.005","volume":"348","author":"KM Frazer","year":"2018","unstructured":"Frazer KM, Richards Q, Keith DR (2018) The long-term effects of cocaine use on cognitive functioning: a systematic critical review. Behav Brain Res 348:241\u2013262","journal-title":"Behav Brain Res"},{"key":"5067_CR36","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/j.1360-0443.2011.03719.x","volume":"107","author":"TP Freeman","year":"2012","unstructured":"Freeman TP, Morgan CJ, Vaughn-Jones J, Hussain N, Karimi K, Curran HV (2012) Cognitive and subjective effects of mephedrone and factors influencing use of a 'new legal high. Addiction 107:792\u2013800","journal-title":"Addiction"},{"key":"5067_CR37","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.forsciint.2018.07.001","volume":"290","author":"H Gaspar","year":"2018","unstructured":"Gaspar H, Bronze S, Oliveira C, Victor BL, Machuqueiro M, Pacheco R, Caldeira MJ, Santos S (2018) Proactive response to tackle the threat of emerging drugs: synthesis and toxicity evaluation of new cathinones. Forensic Sci Int 290:146\u2013156","journal-title":"Forensic Sci Int"},{"key":"5067_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.brainresbull.2016.04.011","volume":"126","author":"RA Glennon","year":"2016","unstructured":"Glennon RA, Young R (2016) Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and alpha-pyrrolidinovalerophenone (alpha-PVP). Brain Res Bull 126:111\u2013126","journal-title":"Brain Res Bull"},{"key":"5067_CR39","first-page":"4","volume":"5","author":"TJ Gould","year":"2010","unstructured":"Gould TJ (2010) Addiction and cognition. Addict Sci Clin Pract 5:4\u201314","journal-title":"Addict Sci Clin Pract"},{"key":"5067_CR40","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neuropharm.2016.04.014","volume":"108","author":"RA Gregg","year":"2016","unstructured":"Gregg RA, Hicks C, Nayak SU, Tallarida CS, Nucero P, Smith GR, Reitz AB, Rawls SM (2016) Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator. Neuropharmacology 108:111\u2013119","journal-title":"Neuropharmacology"},{"key":"5067_CR41","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1080\/15548627.2015.1052205","volume":"11","author":"ML Guo","year":"2015","unstructured":"Guo ML, Liao K, Periyasamy P, Yang L, Cai Y, Callen SE, Buch S (2015) Cocaine-mediated microglial activation involves the ER stress-autophagy axis. Autophagy 11:995\u20131009","journal-title":"Autophagy"},{"key":"5067_CR42","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1124\/jpet.111.184119","volume":"339","author":"GC Hadlock","year":"2011","unstructured":"Hadlock GC, Webb KM, McFadden LM, Chu PW, Ellis JD, Allen SC, Andrenyak DM, Vieira-Brock PL, German CL, Conrad KM, Hoonakker AJ, Gibb JW, Wilkins DG, Hanson GR, Fleckenstein AE (2011) 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse. J Pharmacol Exp Ther 339:530\u2013536","journal-title":"J Pharmacol Exp Ther"},{"key":"5067_CR43","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/npp.2011.276","volume":"37","author":"CL Hart","year":"2012","unstructured":"Hart CL, Marvin CB, Silver R, Smith EE (2012) Is cognitive functioning impaired in methamphetamine users? A critical review. Neuropsychopharmacology 37:586\u2013608","journal-title":"A critical review. Neuropsychopharmacology"},{"key":"5067_CR44","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/hup.2307","volume":"28","author":"DA Herzig","year":"2013","unstructured":"Herzig DA, Brooks R, Mohr C (2013) Inferring about individual drug and schizotypy effects on cognitive functioning in polydrug using mephedrone users before and after clubbing. Hum Psychopharmacol 28:168\u2013182","journal-title":"Hum Psychopharmacol"},{"key":"5067_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000338285","volume":"19","author":"R Hoffman","year":"2013","unstructured":"Hoffman R, Al\u2019absi M (2013a) Working memory and speed of information processing in chronic khat users: preliminary findings. Eur Addict Res 19:1\u20136","journal-title":"Eur Addict Res"},{"key":"5067_CR46","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1111\/add.12260","volume":"108","author":"R Hoffman","year":"2013","unstructured":"Hoffman R, Al\u2019absi M (2013b) Concurrent use of khat and tobacco is associated with verbal learning and delayed recall deficits. Addiction 108:1855\u20131862","journal-title":"Addiction"},{"key":"5067_CR47","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1007\/s00213-018-4953-1","volume":"235","author":"L Homman","year":"2018","unstructured":"Homman L, Seglert J, Morgan MJ (2018) An observational study on the sub-acute effects of mephedrone on mood, cognition, sleep and physical problems in regular mephedrone users. Psychopharmacology 235:2609\u20132618","journal-title":"Psychopharmacology"},{"key":"5067_CR48","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/08897077.2013.832469","volume":"35","author":"AA Ismail","year":"2014","unstructured":"Ismail AA, El Sanosy RM, Rohlman DS, El-Setouhy M (2014) Neuropsychological functioning among chronic khat users in Jazan region, Saudi Arabia. Subst Abus 35:235\u2013244","journal-title":"Subst Abus"},{"key":"5067_CR49","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.tips.2003.09.006","volume":"24","author":"EH Jacobs","year":"2003","unstructured":"Jacobs EH, Smit AB, De Vries TJ, Schoffelmeer ANM (2003) Neuroadaptive effects of active versus passive drug administration in addiction research. Trends Pharmacol Sci 24:566\u2013573","journal-title":"Trends Pharmacol Sci"},{"key":"5067_CR50","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0014-2999(80)90326-X","volume":"68","author":"P Kalix","year":"1980","unstructured":"Kalix P (1980) A constituent of khat leaves with amphetamine-like releasing properties. Eur J Pharmacol 68:213\u2013215","journal-title":"Eur J Pharmacol"},{"key":"5067_CR51","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/BF00427108","volume":"74","author":"P Kalix","year":"1981","unstructured":"Kalix P (1981) Cathinone, an alkaloid from khat leaves with an amphetamine-like releasing effect. Psychopharmacology 74:269\u2013270","journal-title":"Psychopharmacology"},{"key":"5067_CR52","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0364-7722(82)80106-9","volume":"6","author":"P Kalix","year":"1982","unstructured":"Kalix P (1982) The amphetamine-like releasing effect of the alkaloid (\u2212)cathinone on rat nucleus accumbens and rabbit caudate nucleus. Prog Neuro-Psychopharmacol Biol Psychiatry 6:43\u201349","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"5067_CR53","doi-asserted-by":"crossref","unstructured":"Kaminska K, Noworyta-Sokolowska K, Gorska A, Rzemieniec J, Wnuk A, Wojtas A, Kreiner G, Kajta M, Golembiowska K (2018) The effects of exposure to mephedrone during adolescence on brain neurotransmission and neurotoxicity in adult rats. Neurotox Res","DOI":"10.1007\/s12640-018-9908-0"},{"key":"5067_CR54","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/1570159X13666141210225009","volume":"13","author":"SB Karch","year":"2015","unstructured":"Karch SB (2015) Cathinone neurotoxicity (\u201cthe 3Ms\u201d). Curr Neuropharmacol 13:21\u201325","journal-title":"Curr Neuropharmacol"},{"key":"5067_CR55","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neuropharm.2017.10.007","volume":"134","author":"L Karila","year":"2018","unstructured":"Karila L, Lafaye G, Scocard A, Cottencin O, Benyamina A (2018) MDPV and a-PVP use in humans: the twisted sisters. Neuropharmacology 134:65\u201372","journal-title":"Neuropharmacology"},{"key":"5067_CR56","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/bcpt.12253","volume":"115","author":"L Karlsson","year":"2014","unstructured":"Karlsson L, Andersson M, Kronstrand R, Kugelberg FC (2014) Mephedrone, methylone and 3,4-methylenedioxypyrovalerone (MDPV) induce conditioned place preference in mice. Basic Clin Pharmacol Toxicol 115:411\u2013416","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"5067_CR57","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/978-1-62703-050-2_19","volume":"929","author":"EM Kenyon","year":"2012","unstructured":"Kenyon EM (2012) Interspecies extrapolation. Methods Mol Biol 929:501\u2013520","journal-title":"Methods Mol Biol"},{"key":"5067_CR58","first-page":"739","volume":"66","author":"NY Khattab","year":"1995","unstructured":"Khattab NY, Amer G (1995) Undetected neuropsychophysiological sequelae of khat chewing in standard aviation medical examination. Aviat Space Environ Med 66:739\u2013744","journal-title":"Aviat Space Environ Med"},{"key":"5067_CR59","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.bbr.2008.05.022","volume":"195","author":"ST Kimani","year":"2008","unstructured":"Kimani ST, Nyongesa AW (2008) Effects of single daily khat (Catha edulis) extract on spatial learning and memory in CBA mice. Behav Brain Res 195:192\u2013197","journal-title":"Behav Brain Res"},{"key":"5067_CR60","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11011-015-9738-1","volume":"31","author":"ST Kimani","year":"2016","unstructured":"Kimani ST, Patel NB, Kioy PG (2016) Memory deficits associated with khat (Catha edulis) use in rodents. Metab Brain Dis 31:45\u201352","journal-title":"Metab Brain Dis"},{"key":"5067_CR61","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/ejn.13363","volume":"45","author":"SJ Kish","year":"2017","unstructured":"Kish SJ, Boileau I, Callaghan RC, Tong J (2017) Brain dopamine neurone \u2018damage\u2019: methamphetamine users vs. Parkinson\u2019s disease - a critical assessment of the evidence. Eur J Neurosci 45:58\u201366","journal-title":"Eur J Neurosci"},{"key":"5067_CR62","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4161\/23328940.2014.969074","volume":"1","author":"EA Kiyatkin","year":"2014","unstructured":"Kiyatkin EA (2014) State-dependent and environmental modulation of brain hyperthermic effects of psychoactive drugs of abuse. Temperature (Austin) 1:201\u2013213","journal-title":"Temperature (Austin)"},{"key":"5067_CR63","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1021\/cn4001236","volume":"4","author":"R Kolanos","year":"2013","unstructured":"Kolanos R, Solis EJ, Sakloth F, De Felice LJ, Glennon RA (2013) \u201cDeconstruction\u201d of the abused synthetic cathinone methylenedioxypyrovalerone (MDPV) and an examination of effects at the human dopamine transporter. ACS Chem Neurosci 4:1524\u20131529","journal-title":"ACS Chem Neurosci"},{"key":"5067_CR64","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/npp.2016.121","volume":"42","author":"MJ Lacagnina","year":"2017","unstructured":"Lacagnina MJ, Rivera PD, Bilbo SD (2017) Glial and neuroimmune mechanisms as critical modulators of drug use and abuse. Neuropsychopharmacology 42:156\u2013177","journal-title":"Neuropsychopharmacology"},{"key":"5067_CR65","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.neulet.2017.06.059","volume":"655","author":"SM Lantz","year":"2017","unstructured":"Lantz SM, Rosas-Hernandez H, Cuevas E, Robinson B, Rice KC, Fantegrossi WE, Imam SZ, Paule MG, Ali SF (2017) Monoaminergic toxicity induced by cathinone phthalimide: an in vitro study. Neurosci Lett 655:76\u201381","journal-title":"Neurosci Lett"},{"key":"5067_CR66","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.neuron.2016.03.030","volume":"90","author":"GM Lewitus","year":"2016","unstructured":"Lewitus GM, Konefal SC, Greenhalgh AD, Pribiag H, Augereau K, Stellwagen D (2016) Microglial TNF-\u03b1 suppresses cocaine-induced plasticity and behavioral sensitization. Neuron 90:483\u2013491","journal-title":"Neuron"},{"key":"5067_CR67","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.drugalcdep.2012.04.021","volume":"126","author":"R Lisek","year":"2012","unstructured":"Lisek R, Xu W, Yuvasheva E, Chiu YT, Reitz AB, Liu-Chen LY, Rawls SM (2012) Mephedrone (\u2018bath salt\u2019) elicits conditioned place preference and dopamine-sensitive motor activation. Drug Alcohol Depend 126:257\u2013262","journal-title":"Drug Alcohol Depend"},{"key":"5067_CR68","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/B978-0-12-801284-0.00007-5","volume":"118","author":"JM Loftis","year":"2014","unstructured":"Loftis JM, Janowsky A (2014) Neuroimmune basis of methamphetamine toxicity. Int Rev Neurobiol 118:165\u2013197","journal-title":"Int Rev Neurobiol"},{"key":"5067_CR69","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.brainres.2014.10.044","volume":"1628","author":"ED London","year":"2015","unstructured":"London ED, Kohno M, Morales AM, Ballard ME (2015) Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging. Brain Res 1628:174\u2013185","journal-title":"Brain Res"},{"key":"5067_CR70","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1007\/s00213-014-3493-6","volume":"231","author":"R Lopez-Arnau","year":"2014","unstructured":"Lopez-Arnau R, Martinez-Clemente J, Abad S, Pubill D, Camarasa J, Escubedo E (2014a) Repeated doses of methylone, a new drug of abuse, induce changes in serotonin and dopamine systems in the mouse. Psychopharmacology 231:3119\u20133129","journal-title":"Psychopharmacology"},{"key":"5067_CR71","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1177\/0269881114548439","volume":"28","author":"R Lopez-Arnau","year":"2014","unstructured":"Lopez-Arnau R, Martinez-Clemente J, Pubill D, Escubedo E, Camarasa J (2014b) Serotonergic impairment and memory deficits in adolescent rats after binge exposure of methylone. J Psychopharmacol 28:1053\u20131063","journal-title":"J Psychopharmacol"},{"key":"5067_CR72","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.taap.2015.03.015","volume":"286","author":"R Lopez-Arnau","year":"2015","unstructured":"Lopez-Arnau R, Martinez-Clemente J, Rodrigo T, Pubill D, Camarasa J, Escubedo E (2015) Neuronal changes and oxidative stress in adolescent rats after repeated exposure to mephedrone. Toxicol Appl Pharmacol 286:27\u201335","journal-title":"Toxicol Appl Pharmacol"},{"key":"5067_CR73","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.tox.2017.06.004","volume":"387","author":"D Luethi","year":"2017","unstructured":"Luethi D, Liechti ME, Krahenbuhl S (2017) Mechanisms of hepatocellular toxicity associated with new psychoactive synthetic cathinones. Toxicology 387:57\u201366","journal-title":"Toxicology"},{"key":"5067_CR74","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.neuropharm.2017.07.026","volume":"134","author":"D Luethi","year":"2018","unstructured":"Luethi D, Kolaczynska KE, Docci L, Krahenbuhl S, Hoener MC, Liechti ME (2018) Pharmacological profile of mephedrone analogs and related new psychoactive substances. Neuropharmacology 134:4\u201312","journal-title":"Neuropharmacology"},{"key":"5067_CR75","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.tins.2012.05.006","volume":"35","author":"JF Marshall","year":"2012","unstructured":"Marshall JF, O'Dell SJ (2012) Methamphetamine influences on brain and behavior: unsafe at any speed? Trends Neurosci 35:536\u2013545","journal-title":"Trends Neurosci"},{"key":"5067_CR76","doi-asserted-by":"publisher","first-page":"e99002","DOI":"10.1371\/journal.pone.0099002","volume":"9","author":"J Martinez-Clemente","year":"2014","unstructured":"Martinez-Clemente J, Lopez-Arnau R, Abad S, Pubill D, Escubedo E, Camarasa J (2014) Dose and time-dependent selective neurotoxicity induced by mephedrone in mice. PLoS One 9:e99002","journal-title":"PLoS One"},{"key":"5067_CR77","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.tox.2017.05.017","volume":"386","author":"T Matsunaga","year":"2017","unstructured":"Matsunaga T, Morikawa Y, Kamata K, Shibata A, Miyazono H, Sasajima Y, Suenami K, Sato K, Takekoshi Y, Endo S, El-Kabbani O, Ikari A (2017) \u03b1-pyrrolidinononanophenone provokes apoptosis of neuronal cells through alterations in antioxidant properties. Toxicology 386:93\u2013102","journal-title":"Toxicology"},{"key":"5067_CR78","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/1742-2094-8-165","volume":"8","author":"A Mayado","year":"2011","unstructured":"Mayado A, Torres E, Gutierrez-Lopez MD, Colado MI, O'Shea E (2011) Increased interleukin-1beta levels following low dose MDMA induces tolerance against the 5-HT neurotoxicity produced by challenge MDMA. J Neuroinflammation 8:165","journal-title":"J Neuroinflammation"},{"key":"5067_CR79","doi-asserted-by":"crossref","unstructured":"Mayer FP, Schmid D, Holy M, Daws LC, Sitte HH (2018a) \"Polytox\" synthetic cathinone abuse: a potential role for organic cation transporter 3 in combined cathinone-induced efflux. Neurochem Int","DOI":"10.1016\/j.neuint.2018.09.008"},{"key":"5067_CR80","doi-asserted-by":"crossref","unstructured":"Mayer FP, Schmid D, Owens WA, Gould GG, Apuschkin M, Kudlacek O, Salzer I, Boehm S, Chiba P, Williams PH, Wu HH, Gether U, Koek W, Daws LC, Sitte HH (2018b) An unsuspected role for organic cation transporter 3 in the actions of amphetamine. Neuropsychopharmacology","DOI":"10.1038\/s41386-018-0053-5"},{"key":"5067_CR81","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.neuro.2015.08.006","volume":"50","author":"SE McConnell","year":"2015","unstructured":"McConnell SE, O'Banion MK, Cory-Slechta DA, Olschowka JA, Opanashuk LA (2015) Characterization of binge-dosed methamphetamine-induced neurotoxicity and neuroinflammation. Neurotoxicology 50:131\u2013141","journal-title":"Neurotoxicology"},{"key":"5067_CR82","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ntt.2017.02.003","volume":"61","author":"NB Miner","year":"2017","unstructured":"Miner NB, O'Callaghan JP, Phillips TJ, Janowsky A (2017) The combined effects of 3,4-methylenedioxymethamphetamine (MDMA) and selected substituted methcathinones on measures of neurotoxicity. Neurotoxicol Teratol 61:74\u201381","journal-title":"Neurotoxicol Teratol"},{"key":"5067_CR83","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.pneurobio.2015.09.011","volume":"155","author":"R Moratalla","year":"2017","unstructured":"Moratalla R, Khairnar A, Simola N, Granado N, Garcia-Montes JR, Porceddu PF, Tizabi Y, Costa G, Morelli M (2017) Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms. Prog Neurobiol 155:149\u2013170","journal-title":"Prog Neurobiol"},{"key":"5067_CR84","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1124\/jpet.116.238501","volume":"362","author":"A Moszczynska","year":"2017","unstructured":"Moszczynska A, Callan SP (2017) Molecular, behavioral, and physiological consequences of methamphetamine neurotoxicity: implications for treatment. J Pharmacol Exp Ther 362:474\u2013488","journal-title":"J Pharmacol Exp Ther"},{"key":"5067_CR85","doi-asserted-by":"publisher","first-page":"e45473","DOI":"10.1371\/journal.pone.0045473","volume":"7","author":"CP Motbey","year":"2012","unstructured":"Motbey CP, Karanges E, Li KM, Wilkinson S, Winstock AR, Ramsay J, Hicks C, Kendig MD, Wyatt N, Callaghan PD, McGregor IS (2012) Mephedrone in adolescent rats: residual memory impairment and acute but not lasting 5-HT depletion. PLoS One 7:e45473","journal-title":"PLoS One"},{"key":"5067_CR86","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1177\/0269881113490325","volume":"27","author":"CP Motbey","year":"2013","unstructured":"Motbey CP, Clemens KJ, Apetz N, Winstock AR, Ramsey J, Li KM, Wyatt N, Callaghan PD, Bowen MT, Cornish JL, McGregor IS (2013) High levels of intravenous mephedrone (4-methylmethcathinone) self-administration in rats: neural consequences and comparison with methamphetamine. J Psychopharmacol 27:823\u2013836","journal-title":"J Psychopharmacol"},{"key":"5067_CR87","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/ntr\/ntt139","volume":"16","author":"M Nakajima","year":"2014","unstructured":"Nakajima M, Hoffman R, Al'Absi M (2014) Poor working memory and reduced blood pressure levels in concurrent users of khat and tobacco. Nicotine Tob Res 16:279\u2013287","journal-title":"Nicotine Tob Res"},{"key":"5067_CR88","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ntt.2018.03.001","volume":"67","author":"G Naseri","year":"2018","unstructured":"Naseri G, Fazel A, Golalipour MJ, Haghir H, Sadeghian H, Mojarrad M, Hosseini M, Shahrokhi Sabzevar S, Beheshti F, Ghorbani A (2018) Exposure to mephedrone during gestation increases the risk of stillbirth and induces hippocampal neurotoxicity in mice offspring. Neurotoxicol Teratol 67:10\u201317","journal-title":"Neurotoxicol Teratol"},{"key":"5067_CR89","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/7854_2016_18","volume":"32","author":"SS Negus","year":"2017","unstructured":"Negus SS, Banks ML (2017) Decoding the structure of abuse potential for new psychoactive substances: structure-activity relationships for abuse-related effects of 4-substituted methcathinone analogs. Curr Top Behav Neurosci 32:119\u2013131","journal-title":"Curr Top Behav Neurosci"},{"key":"5067_CR90","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.drugalcdep.2018.01.013","volume":"186","author":"CF Oliver","year":"2018","unstructured":"Oliver CF, Simmons SJ, Nayak SU, Smith GR, Reitz AB, Rawls SM (2018) Chemokines and \u2018bath salts\u2019: CXCR4 receptor antagonist reduces rewarding and locomotor-stimulant effects of the designer cathinone MDPV in rats. Drug Alcohol Depend 186:75\u201379","journal-title":"Drug Alcohol Depend"},{"key":"5067_CR91","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neuro.2015.08.004","volume":"50","author":"PB Pail","year":"2015","unstructured":"Pail PB, Costa KM, Leite CE, Campos MM (2015) Comparative pharmacological evaluation of the cathinone derivatives, mephedrone and methedrone, in mice. Neurotoxicology 50:71\u201380","journal-title":"Neurotoxicology"},{"key":"5067_CR92","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.drugalcdep.2016.02.001","volume":"161","author":"JJ Palamar","year":"2016","unstructured":"Palamar JJ, Salomone A, Vincenti M, Cleland CM (2016) Detection of \u201cbath salts\u201d and other novel psychoactive substances in hair samples of ecstasy\/MDMA\/\u201cMolly\u201d users. Drug Alcohol Depend 161:200\u2013205","journal-title":"Drug Alcohol Depend"},{"key":"5067_CR93","doi-asserted-by":"publisher","first-page":"738","DOI":"10.2174\/1570159X14666161130130718","volume":"15","author":"F Pantano","year":"2017","unstructured":"Pantano F, Tittarelli R, Mannocchi G, Pacifici R, di Luca A, Busardo FP, Marinelli E (2017) Neurotoxicity induced by mephedrone: an up-to-date review. Curr Neuropharmacol 15:738\u2013749","journal-title":"Curr Neuropharmacol"},{"key":"5067_CR94","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s12640-015-9536-x","volume":"28","author":"RB Pereira","year":"2015","unstructured":"Pereira RB, Andrade PB, Valentao P (2015) A comprehensive view of the neurotoxicity mechanisms of cocaine and ethanol. Neurotox Res 28:253\u2013267","journal-title":"Neurotox Res"},{"key":"5067_CR95","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.addbeh.2018.01.021","volume":"80","author":"S Potvin","year":"2018","unstructured":"Potvin S, Pelletier J, Grot S, Hebert C, Barr AM, Lecomte T (2018) Cognitive deficits in individuals with methamphetamine use disorder: a meta-analysis. Addict Behav 80:154\u2013160","journal-title":"Addict Behav"},{"key":"5067_CR96","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nri3265","volume":"12","author":"RM Ransohoff","year":"2012","unstructured":"Ransohoff RM, Engelhardt B (2012) The anatomical and cellular basis of immune surveillance in the central nervous system. Nat Rev Immunol 12:623\u2013635","journal-title":"Nat Rev Immunol"},{"key":"5067_CR97","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.neulet.2016.06.029","volume":"629","author":"H Rosas-Hernandez","year":"2016","unstructured":"Rosas-Hernandez H, Cuevas E, Lantz SM, Rice KC, Gannon BM, Fantegrossi WE, Gonzalez C, Paule MG, Ali SF (2016) Methamphetamine, 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxypyrovalerone (MDPV) induce differential cytotoxic effects in bovine brain microvessel endothelial cells. Neurosci Lett 629:125\u2013130","journal-title":"Neurosci Lett"},{"key":"5067_CR98","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1124\/jpet.116.237503","volume":"360","author":"S Salim","year":"2017","unstructured":"Salim S (2017) Oxidative stress and the central nervous system. J Pharmacol Exp Ther 360:201\u2013205","journal-title":"J Pharmacol Exp Ther"},{"key":"5067_CR99","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neuropharm.2017.11.034","volume":"134","author":"K Sewalia","year":"2018","unstructured":"Sewalia K, Watterson LR, Hryciw A, Belloc A, Ortiz JB, Olive MF (2018) Neurocognitive dysfunction following repeated binge-like self-administration of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV). Neuropharmacology 134:36\u201345","journal-title":"Neuropharmacology"},{"key":"5067_CR100","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/j.1476-5381.2009.00267.x","volume":"157","author":"V Sharma","year":"2009","unstructured":"Sharma V, McNeill JH (2009) To scale or not to scale: the principles of dose extrapolation. Br J Pharmacol 157:907\u2013921","journal-title":"Br J Pharmacol"},{"key":"5067_CR101","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.euroneuro.2012.09.005","volume":"23","author":"SE Shortall","year":"2013","unstructured":"Shortall SE, Macerola AE, Swaby RT, Jayson R, Korsah C, Pillidge KE, Wigmore PM, Ebling FJ, Green AR, Fone KC, King MV (2013) Behavioural and neurochemical comparison of chronic intermittent cathinone, mephedrone and MDMA administration to the rat. Eur Neuropsychopharmacol 23:1085\u20131095","journal-title":"Eur Neuropsychopharmacol"},{"key":"5067_CR102","first-page":"241","volume":"65","author":"K Siedlecka-Kroplewska","year":"2014","unstructured":"Siedlecka-Kroplewska K, Szczerba A, Lipinska A, Slebioda T, Kmiec Z (2014) 3-Fluoromethcathinone, a structural analog of mephedrone, inhibits growth and induces cell cycle arrest in HT22 mouse hippocampal cells. J Physiol Pharmacol 65:241\u2013246","journal-title":"J Physiol Pharmacol"},{"key":"5067_CR103","doi-asserted-by":"crossref","unstructured":"Siedlecka-Kroplewska K, Wronska A, Stasilojc G, Kmiec Z (2018) The designer drug 3-fluoromethcathinone induces oxidative stress and activates autophagy in HT22 neuronal cells. Neurotox Res","DOI":"10.1007\/s12640-018-9898-y"},{"key":"5067_CR104","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s11419-016-0324-y","volume":"34","author":"B Silva","year":"2016","unstructured":"Silva B, Fernandes C, Tiritan ME, Pinto MM, Valente MJ, Carvalho M, de Pinho PG, Remiao F (2016) Chiral enantioresolution of cathinone derivatives present in \u201clegal highs\u201d, and enantioselectivity evaluation on cytotoxicity of 3,4-methylenedioxypyrovalerone (MDPV). Forensic Toxicol 34:372\u2013385","journal-title":"Forensic Toxicol"},{"key":"5067_CR105","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/7854_2016_20","volume":"32","author":"LD Simmler","year":"2017","unstructured":"Simmler LD, Liechti ME (2017) Interactions of cathinone NPS with human transporters and receptors in transfected cells. Curr Top Behav Neurosci 32:49\u201372","journal-title":"Curr Top Behav Neurosci"},{"key":"5067_CR106","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","volume":"168","author":"LD Simmler","year":"2013","unstructured":"Simmler LD, Buser TA, Donzelli M, Schramm Y, Dieu LH, Huwyler J, Chaboz S, Hoener MC, Liechti ME (2013) Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol 168:458\u2013470","journal-title":"Br J Pharmacol"},{"key":"5067_CR107","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.neuropharm.2013.11.008","volume":"79","author":"LD Simmler","year":"2014","unstructured":"Simmler LD, Rickli A, Hoener MC, Liechti ME (2014) Monoamine transporter and receptor interaction profiles of a new series of designer cathinones. Neuropharmacology 79:152\u2013160","journal-title":"Neuropharmacology"},{"key":"5067_CR108","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1124\/jpet.115.229765","volume":"357","author":"LD Simmler","year":"2016","unstructured":"Simmler LD, Buchy D, Chaboz S, Hoener MC, Liechti ME (2016) In vitro characterization of psychoactive substances at rat, mouse, and human trace amine-associated receptor 1. J Pharmacol Exp Ther 357:134\u2013144","journal-title":"J Pharmacol Exp Ther"},{"key":"5067_CR109","doi-asserted-by":"crossref","unstructured":"Simmons SJ, Leyrer-Jackson JM, Oliver CF, Hicks C, Muschamp JW, Rawls SM, Olive MF (2018) Dark classics in chemical neuroscience: cathinone-derived psychostimulants. ACS Chem Neurosci","DOI":"10.1021\/acschemneuro.8b00147"},{"key":"5067_CR110","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/bs.pbr.2015.07.004","volume":"223","author":"SMA Soleimani","year":"2016","unstructured":"Soleimani SMA, Ekhtiari H, Cadet JL (2016) Drug-induced neurotoxicity in addiction medicine: from prevention to harm reduction. Prog Brain Res 223:19\u201341","journal-title":"Prog Brain Res"},{"key":"5067_CR111","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/7854_2009_23","volume":"3","author":"GD Stuber","year":"2010","unstructured":"Stuber GD, Hopf FW, Tye KM, Chen BT, Bonci A (2010) Neuroplastic alterations in the limbic system following cocaine or alcohol exposure. Curr Top Behav Neurosci 3:3\u201327","journal-title":"Curr Top Behav Neurosci"},{"key":"5067_CR112","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.neulet.2004.06.065","volume":"367","author":"DM Thomas","year":"2004","unstructured":"Thomas DM, Dowgiert J, Geddes TJ, Francescutti-Verbeem D, Liu X, Kuhn DM (2004) Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines. Neurosci Lett 367:349\u2013354","journal-title":"Neurosci Lett"},{"key":"5067_CR113","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00204-013-1163-9","volume":"88","author":"MJ Valente","year":"2014","unstructured":"Valente MJ, Guedes de Pinho P, de Lourdes Bastos M, Carvalho F, Carvalho M (2014) Khat and synthetic cathinones: a review. Arch Toxicol 88:15\u201345","journal-title":"Arch Toxicol"},{"key":"5067_CR114","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1007\/s00204-015-1653-z","volume":"90","author":"MJ Valente","year":"2016","unstructured":"Valente MJ, Araujo AM, Silva R, Bastos Mde L, Carvalho F, Guedes de Pinho P, Carvalho M (2016) 3,4-Methylenedioxypyrovalerone (MDPV): in vitro mechanisms of hepatotoxicity under normothermic and hyperthermic conditions. Arch Toxicol 90:1959\u20131973","journal-title":"Arch Toxicol"},{"key":"5067_CR115","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1007\/s00204-017-1984-z","volume":"91","author":"MJ Valente","year":"2017","unstructured":"Valente MJ, Amaral C, Correia-da-Silva G, Duarte JA, Bastos ML, Carvalho F, Guedes de Pinho P, Carvalho M (2017a) Methylone and MDPV activate autophagy in human dopaminergic SH-SY5Y cells: a new insight into the context of beta-keto amphetamines-related neurotoxicity. Arch Toxicol 91:3663\u20133676","journal-title":"Arch Toxicol"},{"key":"5067_CR116","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1021\/acschemneuro.6b00421","volume":"8","author":"MJ Valente","year":"2017","unstructured":"Valente MJ, Bastos ML, Fernandes E, Carvalho F, Guedes de Pinho P, Carvalho M (2017b) Neurotoxicity of \u03b2-keto amphetamines: deathly mechanisms elicited by methylone and MDPV in human dopaminergic SH-SY5Y cells. ACS Chem Neurosci 8:850\u2013859","journal-title":"ACS Chem Neurosci"},{"key":"5067_CR117","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/0376-8716(82)90067-9","volume":"9","author":"GC Wagner","year":"1982","unstructured":"Wagner GC, Preston K, Ricaurte GA, Schuster CR, Seiden LS (1982) Neurochemical similarities between d,l-cathinone and d-amphetamine. Drug Alcohol Depend 9:279\u2013284","journal-title":"Drug Alcohol Depend"},{"key":"5067_CR118","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/jeab.72","volume":"101","author":"PF Weed","year":"2014","unstructured":"Weed PF, Leonard ST, Sankaranarayanan A, Winsauer PJ (2014) Estradiol administration to ovariectomized rats potentiates mephedrone-induced disruptions of nonspatial learning. J Exp Anal Behav 101:303\u2013315","journal-title":"J Exp Anal Behav"},{"key":"5067_CR119","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fpsyt.2017.00156","volume":"8","author":"AM Weinstein","year":"2017","unstructured":"Weinstein AM, Rosca P, Fattore L, London ED (2017) Synthetic cathinone and cannabinoid designer drugs pose a major risk for public health. Front Psych 8:156","journal-title":"Front Psych"},{"key":"5067_CR120","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s12640-016-9640-6","volume":"30","author":"J Wojcieszak","year":"2016","unstructured":"Wojcieszak J, Andrzejczak D, Woldan-Tambor A, Zawilska JB (2016) Cytotoxic activity of pyrovalerone derivatives, an emerging group of psychostimulant designer cathinones. Neurotox Res 30:239\u2013250","journal-title":"Neurotox Res"},{"key":"5067_CR121","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1124\/pr.112.007054","volume":"66","author":"S Wood","year":"2014","unstructured":"Wood S, Sage JR, Shuman T, Anagnostaras SG (2014) Psychostimulants and cognition: a continuum of behavioral and cognitive activation. Pharmacol Rev 66:193\u2013221","journal-title":"Pharmacol Rev"},{"key":"5067_CR122","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1111\/j.1476-5381.2012.02091.x","volume":"167","author":"MJ Wright Jr","year":"2012","unstructured":"Wright MJ Jr, Vandewater SA, Angrish D, Dickerson TJ, Taffe MA (2012) Mephedrone (4-methylmethcathinone) and d-methamphetamine improve visuospatial associative memory, but not spatial working memory, in rhesus macaques. Br J Pharmacol 167:1342\u20131352","journal-title":"Br J Pharmacol"},{"key":"5067_CR123","first-page":"268","volume":"22","author":"S Zaami","year":"2018","unstructured":"Zaami S, Giorgetti R, Pichini S, Pantano F, Marinelli E, Busardo FP (2018) Synthetic cathinones related fatalities: an update. Eur Rev Med Pharmacol Sci 22:268\u2013274","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-018-5067-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-018-5067-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-018-5067-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T20:47:56Z","timestamp":1720730876000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-018-5067-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,27]]},"references-count":123,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["5067"],"URL":"https:\/\/doi.org\/10.1007\/s00213-018-5067-5","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,27]]},"assertion":[{"value":"30 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}